Related Experiment Video
Updated: Jul 6, 2026

11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Chimerism analysis following nonmyeloablative stem cell transplantation using a new cell subset separation method:
V Decot1, V Latger-Cannard, T Lecompte
1Cell Therapy Unit and Tissue Bank, CHU Nancy Brabois, Vandoeuvre-Les-Nancy, France.
Bio-Medical Materials and Engineering
|May 6, 2008
Summary
The Robosep device improves cell purification for chimerism analysis after allogeneic stem cell transplantation, enhancing both purity and recovery, especially for low-frequency cell populations.
Area of Science:
- Hematology
- Transplantation Immunology
Background:
- Chimerism analysis is crucial for managing patients post-allogeneic stem cell transplantation.
- Monitoring donor and host cell proportions helps detect disease recurrence.
Purpose of the Study:
- To evaluate the performance of the automated Robosep device for cell subset isolation.
- To compare Robosep against manual techniques (RosetteSep, Polymorphprep) for T cell and granulocyte purification.
Main Methods:
- Automated cell isolation using the Robosep device.
- Manual cell isolation using RosetteSep (T cells) and Polymorphprep (granulocytes).
- Chimerism analysis on purified T cells (CD3+) and granulocytes (CD15+, CD66+/CD33+).
Main Results:
- Robosep significantly improved T cell purity (98.42% vs. 92.42%) and recovery (63.43% vs. 38%) compared to RosetteSep.
- For patient samples with <10% CD3+ cells, Robosep showed superior purity (90% vs. 44.44%) and recovery (73.79% vs. 43.98%).
- Robosep enhanced granulocyte purity (96.90% vs. 86.20%) but initially showed lower recovery (35.2% vs. 52.30%), which was improved using a myeloid cocktail (64.04%).
Conclusions:
- The Robosep device offers efficient and improved cell purification for chimerism analysis.
- It is particularly effective for isolating low-frequency cell populations in the post-transplant period.
- Robosep represents a valuable advancement for managing patients undergoing allogeneic stem cell transplantation.

